Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.56 |
| ▸ | TDO2 | P48775 | 3/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.45 |
| ▸ | USP8 | P40818 | 1/20 | 0.43 |
| ▸ | USP7 | Q93009 | 1/20 | 0.43 |
| ▸ | USP47 | Q96K76 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.39 |
| ▸ | USP1 | O94782 | 1/20 | 0.39 |
| ▸ | USP19 | O94966 | 1/20 | 0.39 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7812894 | 1.00 | IDO1 (0.56) | IDO1TDO2PTGS2USP8USP7 | |
| SCHEMBL7812893 | 0.92 | IDO1 (0.51) | IDO1TDO2PTGS2USP8USP7 | |
| SCHEMBL7812596 | 0.92 | IDO1 (0.51) | IDO1TDO2PTGS2USP8USP7 | |
| SCHEMBL7805861 | 0.92 | IDO1 (0.60) | IDO1TDO2PTGS2USP8USP7 | |
| SCHEMBL7805662 | 0.92 | IDO1 (0.60) | IDO1TDO2PTGS2USP8USP7 | |
| SCHEMBL7805767 | 0.88 | IDO1 (0.71) | IDO1TDO2PTGS2ALOX5PTGS1 | |
| SCHEMBL12973015 | 0.81 | PTGS2 (0.54) | IDO1TDO2PTGS2ALOX5PTGS1 | |
| SCHEMBL7813017 | 0.79 | IDO1 (0.43) | IDO1TDO2USP8USP7USP47 | |
| SCHEMBL7813184 | 0.79 | IDO1 (0.43) | IDO1TDO2USP8USP7USP47 | |
| SCHEMBL7805716 | 0.79 | IDO1 (0.62) | IDO1TDO2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0876356-B1 | USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF | INNOTHERA SA LAB (FR) | 2001-10-31 | — | — | EP | claimed |
| EP-0876356-B1 | USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF | INNOTHERA SA LAB (FR) | 2001-10-31 | — | — | EP | disclosed |
| US-6262095-B1 | TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA | LABORATOIRE INNOTHERA (FR) | 2001-07-17 | — | — | US | disclosed |